title: HO prevention and the combined therapeutic protocol--do we really need it?
authors.forename: Kamil Cagri
authors.initials: KC
authors.lastname: Kose
authors.forename: Oguz
authors.initials: O
authors.lastname: Cebesoy
authors.forename: Levent
authors.initials: L
authors.lastname: Altinel
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D008297:Male; D009999:Ossification, Heterotopic / Q000209:etiology / Q000517:prevention & control*; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control*; D011878:Radiotherapy; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007213:Indomethacin